A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.
NCT00471159 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2015-05-04
Summary
To assess the efficacy and safety of PF-3512676 administered in combination with docetaxel for the treatment of patients with advanced breast cancer.
Conditions
- Breast Neoplasms
Interventions
- DRUG
- DRUG
-
PF-3512676
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-08-31
More Related Trials
-
Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer
NCT00006120 ·Status: UNKNOWN ·Phase: PHASE2
-
Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
NCT00002662 ·Status: COMPLETED ·Phase: PHASE3
-
Docetaxel in Breast Cancer
NCT00312208 ·Status: COMPLETED ·Phase: PHASE3
-
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
NCT01547741 ·Status: UNKNOWN ·Phase: PHASE3
-
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
NCT00004125 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer
NCT00080626 ·Status: TERMINATED ·Phase: PHASE2
-
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
NCT00003035 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer
NCT00004175 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Docetaxel in Breast Cancer Patients
NCT00174707 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Dense TC + Pegfilgrastim Support for Breast Cancer
NCT01671319 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel in Treating Patients With Metastatic Breast Cancer
NCT00008411 ·Status: COMPLETED ·Phase: PHASE3
-
Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer
NCT00003066 ·Status: UNKNOWN ·Phase: PHASE2
-
Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line Treatment
NCT01320111 ·Status: COMPLETED ·Phase: PHASE2
-
Doxorubicin in Treating Women With Advanced Breast Cancer
NCT00003165 ·Status: UNKNOWN ·Phase: PHASE2
-
A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer
NCT01351597 ·Status: UNKNOWN ·Phase: PHASE2
-
Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention
NCT00847444 ·Status: UNKNOWN ·Phase: PHASE3
-
CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
NCT03568422 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Biweekly Docetaxel in Patients With Metastatic Breast Cancer.
NCT02041351 ·Status: COMPLETED ·Phase: PHASE2
-
Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
NCT00005800 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
NCT00703326 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer
NCT00364611 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
NCT00003953 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
NCT00343512 ·Status: TERMINATED ·Phase: PHASE2
-
Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer
NCT00191243 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
NCT00079118 ·Status: COMPLETED ·Phase: PHASE2